?cirrhotic

cirrhotic 發(fā)音

英：[s??rɑ?t?k]　　美：[s??r?t?k]

英：　　美：

cirrhotic 中文意思翻譯

cirrhotic 短語詞組

1、cirrhotic gastritis ─── [醫(yī)]硬變性胃炎

2、cirrhotic liver disease ─── 肝硬化

3、cirrhotic inflammation ─── [醫(yī)]硬變性炎癥：同atrophic inflammation

4、cirrhotic tuberculosis ─── [醫(yī)] 閉鎖性肺結(jié)核, 非開放性肺結(jié)核

5、cirrhotic liver ─── [醫(yī)] 硬變肝

6、cirrhotic kidney ─── [醫(yī)] 硬變腎, 固縮腎, ─── [顆]粒狀腎

7、cirrhotic edema ─── 肝硬化水腫

8、cirrhotic care ─── 肝硬化護理

9、cirrhotic bleed ─── 肝硬化出血

10、cirrhotic nash ─── 肝硬化納什

11、cirrhotic color ─── 肝硬化色

12、biliary cirrhotic liver ─── [醫(yī)] 膽汁性肝硬變

cirrhotic 詞性/詞形變化，cirrhotic變形

名詞復數(shù)形式:cirrhotics

cirrhotic 相似詞語短語

1、cirrhi ─── 西里

2、cirrhosed ─── 肝硬化

3、diorthotic ─── 二正統(tǒng)的

4、cerotic ─── 銅黃

5、dichotic ─── adj.二重聽覺的

6、cirrhoses ─── n.硬化；肝硬化(cirrhosis的變形)

7、diarrhoetic ─── 腹瀉

8、dicrotic ─── adj.二重脈搏的，重脈的

9、cirrhosis ─── n.硬化；[內(nèi)科]肝硬化

cirrhotic 常見例句（雙語使用場景）

1、Results There was no significant difference in the level of leptin of the cirrhotic patients and the controls. ─── 結(jié)果肝硬化患者血清瘦素水平同對照組相比差異不顯著；

2、Study of the Average Grey Scale Values and Color Point Percentage in Normal and Cirrhotic Livers before and after Levovist Enhancement ─── 利聲顯增強前后正常肝和肝硬化平均灰度值和彩點百分比研究

3、cirrhotic liver ─── [醫(yī)] 硬變肝

4、Early detection of neuropsychological dysfunction in cirrhotic patients without overt encephalopathy is essential to their prognosis and quality of life. ─── 早期探測肝硬化患者神經(jīng)精神障礙對于患者的預后及提高生活質(zhì)量是很重要的。

5、Effects of preoperative ultraviolet blood irradiation oxygen therapy on cirrhotic patients with hepatocirrhosis portal hypertension ─── 術(shù)前光量子血氧療法對肝硬化門靜脈高壓癥的影響

6、In this study the appropriate values of sensitivity, specificity and effectiveness of TSA in effusions for cancer and cirrhotic obtained were 88%,90.47% and 89.13% respectively. ─── 以肝硬化組的 TSA+2SD 作為惡性組和肝硬化組的鑒別值,其敏感性為88%,特異性為90.47%,有效性為89.13%。 LSA 則無鑒別價值。

7、Abstract ABSTRACT:Objective To research on the main pattern of hepatic cells death during hepatic ischemia/reperfusion(I/R) injury in cirrhotic rat. ─── 摘要 摘要：目的 研究肝硬化大鼠肝缺血再灌注(I/R)損傷時肝細胞死亡的主要方式。

8、He illustrated his point with a slide of a cross-sectional sample from a cirrhotic liver on which he overlaid biopsy needle placement. ─── 他用一組硬化患者肝穿的橫斷面樣本幻燈解釋示意。

9、So it is recommended that DSCS be employed for the treatment of the lesions of gastric mucosa in case of cirrhotic portal hypertension. ─── DSCS術(shù)后選擇性改善了胃底部的微循環(huán)及功能，對治療粘膜病變有一定意義。

10、Diagnostic value of multi-slice CT angiography in different collateral pathways: pancreatic versus cirrhotic portal hypertension ─── 多層螺旋CT血管成像診斷胰源性與肝硬化門脈高壓不同側(cè)支循環(huán)的價值

11、The efficacy and safety of a branched-chain amino acids granules in the treatment of cirrhotic hypoproteinemia--A multicenter, randomised, control study ─── 復方支鏈氨基酸顆粒劑治療肝硬化低蛋白血癥多中心臨床觀察

12、Pericardial devascularization plus endoscopic variceal ligation(EVL) was applied in our hospital as a new union devascularization therapy for 66 cirrhotic portal hypertension patients since 1993. ─── 1993年以來,我院應用賁門周圍血管離斷術(shù)加內(nèi)鏡下曲張靜脈套扎術(shù)治療門靜脈高壓癥66例。

13、Methods A control study was performed to compare two cirrhotic groups:25 cases with gallstone(gallstone group),30 cases without gallstone(control group). ─── 方法:采用病例對照研究法,25例肝硬化合并膽石癥患者為膽石組,30例肝硬化無膽石癥患者為對照組。

14、At the time of first postoperative week, the mean blood glucose value in the 120-minute OGTT in each PAD, PCS and DSCS groups had significant differences compared with the cirrhotic control group (P < 0.05). ─── 術(shù)后第1周DSCS、PAD、PCS組OGTT 120 min血糖值分別為(12.2±2.6)、(12.4±2.8)和(12.6±2.7)mmol/L比肝硬化對照組(9.0±2.4)mmol/L有顯著升高;

15、Reduced expression and dynamic alteration of growth hormone receptors in cirrhotic hepatocytes of rats ─── 實驗性肝硬化肝細胞生長激素受體的表達與動態(tài)變化

16、Evaluateing prognosis of cirrhotic patients by MELD score combined with serum bilirubin ─── MELD評分聯(lián)合血清膽紅素水平預測肝硬化預后

17、The changes of plasma renin activity in cirrhotic patients with ascites undergoing portacaval shunt ─── 合并腹水的門靜脈高壓癥患者門腔靜脈分流術(shù)前后血中腎素活性的變化

18、The cirrhotic process obstructs the intrahepatic portion of the portal venous system. ─── 使門脈系統(tǒng)的肝內(nèi)部分受阻。

19、In these cirrhotic patients, the initial presentation of brain abscess may not be fever or leukocytosis , but focal neurologic deficits. ─── 而在這些肝硬化患者中，腦膿瘍剛開始的臨床表現(xiàn)可能不是發(fā)燒或白血球上升，而是局部的神經(jīng)學上缺失。

20、Effects of Nitric Oxide, Interleukin 2 and Interleukin 8 on Portal Hemodynamics of Cirrhotic Patients ─── 一氧化氮與白介素2、8對肝硬化門脈系統(tǒng)血流量的影響

21、Chu YK, Ma QJ, Liu W, et al.Pathomorphological change in gastric mucosa after liver ischemia reperfusion in cirrhotic rats [J].J Hepatobil Surg, 2003, 11(1): 70-1. ─── [11]褚延魅,馬慶久,劉維,等.肝硬化鼠肝缺血再灌注胃粘膜病理損傷的研究[J].肝膽外科雜志,2003,11(1):70-1.

22、Endothelium-dependent Relaxation Effect of Rhizoma Al ismatis in Aortic Rings of Liver Cirrhotic Rats ─── 澤瀉對肝硬變大鼠主動脈的擴血管作用及機制

23、biliary cirrhotic liver ─── [醫(yī)] 膽汁性肝硬變

24、The other component includes metachronous tumors that arise de novo in a preneoplastic cirrhotic liver. ─── 其他成分，包括在腫瘤（發(fā)生）前的硬變肝內(nèi)出現(xiàn)新形成的異時腫瘤。

25、Abstract Objective To evaluate the role of nitric oxide(NO) in hyperdynamic circulation in cirrhotic portal hypertension. ─── 摘 要 目的 探討NO在肝硬變門脈高壓血流動力學中的作用。

26、Methods: The clinical data, the results of bacterial culture and drug sensitivity tests of 108 ascitic specimens from cirrhotic patients with SBP were analyzed retrospectively. ─── 方法：對108例次腹水細菌培養(yǎng)陽性肝硬化腹水合并SBP患者的臨床資料以及腹水細菌培養(yǎng)和藥物敏感試驗結(jié)果進行回顧性分析。

27、Methods The literatures of the recent years on influence of hepatic cirrhotic portal hypertension on liver transplantation were reviewed. ─── 方法對近年來有關肝硬變門靜脈高壓及其合并癥對肝移植的影響的文獻進行系統(tǒng)分析。

28、Expression of Growth Hormone Receptor mRNA in Hepatocellular Carcinoma and Matched Para- Cancer Cirrhotic Liver Tissue ─── 生長激素受體mRNA在肝細胞癌和癌旁肝硬化組織中的表達

29、Prof.McCullough: Every cirrhotic patient has a loss in protein even if it is undetectable by standard methods clinically. ─── 每位肝硬化患者都存在蛋白質(zhì)過多的損耗，有時甚至使用標準臨床方法也檢測不出來。

30、Methods There were 52 patients including 26 with primary hepatocellular carcinoma and 26 with liver cirrhotic nodules. ─── 方法選取52例患者，其中原發(fā)性肝細胞癌26例，肝硬化結(jié)節(jié)26例。

31、Influence of Radix Angelicae Sinensis on splanchnic plasma TXA_2 and PGI_2 levels in cirrhotic dog ─── 當歸對膽管結(jié)扎肝硬化犬血漿TXA_2/PGI_2水平的影響

32、Portal-azygous devascularization can maintain PVP and PG in portal vein and do not affect liver function of the control rats but it can damage liver cell in cirrhotic rats. ─── 斷流術(shù)能維持PVP及門脈血PG水平，對正常大鼠肝功能影響小，但對肝硬變大鼠的肝細胞有損害。

33、Abstract： Objective：To observe the protective function of arginine to liver in the cirrhotic rats administrated by TPN. ─── 摘 要： 目的:觀察精氨酸對肝硬化大鼠全胃腸外營養(yǎng)時的肝保護作用。

34、Perhaps, the authors suggest, the "critically ill cirrhotic" should be a new prognostic stage. ─── 筆者認為，或許“病重肝硬化”應該是一個新的預后階段。

35、Effect of somatostatin on portal and hepatic hemodynamics and portal venous pressure in cirrhotic patients with portal hypertension ─── 生長抑素對肝硬變門靜脈高壓癥患者門靜脈、肝靜脈血流和門靜脈壓力的影響

36、At the time of enrolment, HCC was diagnosed in 20 cirrhotic patients. ─── 在入選登記時，有20例肝硬化患者被診斷出患有肝細胞癌證。

37、Method 80 cirrhotic patients accepted gastric endoscpy and CT examine,measure the diameter of esophageal varices in the esophageal lumina of CT image. ─── 方法選擇80位肝硬化患者,所有患者均接受胃鏡及食道CT檢查,測量CT圖像下食管腔內(nèi)曲張食道靜脈直徑。

38、Utsunomiya T,Matsumata T.Metastatic carcinoma in the cirrhotic liver.Am J Surg 1993;166:776 ─── 夏振龍.大腸癌肝轉(zhuǎn)移的發(fā)生率及臨床特點.中國實用外科雜志1999;19:579

39、Effects of Glypressin on Gastric Mucosal Blood Flow and Vaso-active Substances in Cirrhotic Rats ─── 可利新對肝硬化大鼠胃粘膜血流量及血管活性物質(zhì)的影響

40、The positive rate for both HBV (HBsAg and/or HBcAg) and HCV Ag was also increased in HCC group (14/39,35.89%) compared with cirrhotic group(9/48, 18.75%),but did not reach statistical significance. ─── HBV和HCV抗原同時陽性者在HCC組(14/39,35.89%)高于肝硬化組(9/48,18.7%),但其差別亦達不到統(tǒng)計學顯著性.

41、Objective To analyze the cause of in-hospital death from variceal bleeding in cirrhotic patients with portal hypertension. ─── 摘要目的探討肝硬化門靜脈高壓癥食管胃底曲張靜脈破裂出血患者住院期間的死亡原因。

42、Objective: To evaluate the efficacy of endoscopic variceal ligation (EVL) combined with partial splenic embolization (PSE) in the treatment of cirrhotic patients with portal hypertension. ─── 摘要目的：探討內(nèi)鏡靜脈套扎(EVL)和部分性脾栓塞(PSE)聯(lián)合治療肝硬化門脈高壓癥的效果。

43、CAO ZX, CHEN XP, WU ZD.The changes of immune function af ter hepatectomy for hepatocellular carcinoma in cirrhotic patients[J].Chin J Gen Surg, 2002, 17(6): 328-9. ─── [6]曹志新,陳孝平,吳在德.肝細胞癌合并肝硬化患者肝切除聯(lián)合脾切除的臨床意義探討[J].中華普通外科雜志,2002,17(6):328-9.

44、Expression of nitric oxide synthase in human hepatocellular carcinoma and cirrhotic liver tissue and its clinical significance. ─── 一氧化氮合酶在原發(fā)性肝癌及癌旁肝硬化組織中的表達及其意義。

45、2 Utsunomiya T, Matsumata T. Metastatic carcinoma in the cirrhotic liver. Am J Surg 1993;166:776 ─── 1夏振龍.大腸癌肝轉(zhuǎn)移的發(fā)生率及臨床特點.中國實用外科雜志1999;19:579

46、Objective: to observe the protective function of arginine to liver in the cirrhotic rats administrated by TPN. ─── 目的：觀察精氨酸對肝硬化大鼠全胃腸外營養(yǎng)時的肝保護作用。

47、The Clinical Observation of Cirrhotic Portal Hypertension TIPSS Treated and TIPSS with SEEV(Analysis of 84 caes) ─── TIPSS與TIPSS并用SEEV治療肝硬變門靜脈高壓的臨床觀察（附84例報告）

48、Methods Seasonal changes of 524 times of upper digestive tract hemorrhage occurring in 370 cases of cirrhotic portal hypertension were retrospectively analyzed. ─── 方法對370例肝炎肝硬化門脈高壓患者發(fā)生的524例次上消化道出血的四季分布進行了回顧性調(diào)查。

49、Abstract AIM: To established a rats cirrhotic model by a small dose of endotoxin injection peritoneally and clarify its possible pathogenesis. ─── 摘 要 目的： 觀察外源性內(nèi)毒素誘發(fā)肝硬化大鼠發(fā)生肝性腦病的可能性及可能機制。

50、Methods The clinical data of variceal bleeding in cirrhotic patients with portal hypertension admitted in recent three years to our hospital were analyzed retrospectively. ─── 方法對近3年收治的186例患者及在住院期內(nèi)死亡的24例患者的臨床資料進行回顧性分析。

51、Effect of eNOS Gene Transfer on the Capacity of Hepatic Sinusoids in cirrhotic rats. ─── eNOS基因治療對肝硬化大鼠肝竇容積的影響

52、18 Mccormic CK PA,Dick R,Siving OS.Octreotide reduce azygos blood flow in cirrhotic patients with portal hypertention. ─── 17張素惠，周建芳.奧曲肽治療老年人食管靜脈曲張破裂出血臨床分析.世界華人消化雜志1999;7：733

53、In conclusion, congestive gastropathy is a common finding in cirrhotic patients.Its appearance is closely correlated with the severity of liver disease. ─── 因此我們的結(jié)論是：（1）郁性胃病變常見于肝硬病人且和肝病嚴重程度有關。

54、Color doppler study of fasting and postprandial hemodynamic changes in hepatic artery and portal vein in cirrhotic patients ─── 彩色多普勒對肝硬化患者入肝血管的血流動力學研究

55、For cirrhotic patients, perhaps you can't stop treatment. ─── 對肝硬化的患者，可能不能停止治療。

56、Materials and methods67 cases of patients with cirrhotic ascites,39 cases with carcinous ascites, 14 cases with tuberculosic ascites were examized ultrasonograhically. ─── 材料與方法通過對肝硬化腹水67例，癌性腹水39例，結(jié)核性腹水14例進行觀察，分析不同原因腹水患者的膽囊、腸管、腹水及腹膜的變化。

57、Patients and methods: Sixty-six patients with fibrotic to cirrhotic hepatitis C virus-related CLD， were consecutively included upon referral to our haemodynamic laboratory. ─── 患者和方法： 推薦到我們的血液動力學實驗室的連續(xù)的66名CLD患者進入了本研究，他們是丙肝病毒相關的肝纖維化或肝硬化的患者。

58、AIM: To established a rats cirrhotic model by a small dose of endotoxin injection peritoneally and clarify its possible pathogenesis. ─── 目的：觀察外源性內(nèi)毒素誘發(fā)肝硬化大鼠發(fā)生肝性腦病的可能性及可能機制。

59、This lesion should be suspected whenever a cirrhotic patient exhibits unexplained clinical deterioration. ─── 不論何時,凡肝硬變患者一旦出現(xiàn)原因不明的衰弱,都應懷疑肝癌.

60、Keywords Rat Cirrhotic liver Magnetic resonance imaging Magnetization transfer contrast; ─── 大鼠;肝硬化;磁共振成像;磁化傳遞對比;

61、CLINICAL ANALYSIS ON TREATING 46 CASES OF CIRRHOTIC PORTAL HYPERTENTION WITH PROSTAGLANDIN E 1 ─── 前列腺素E_1治療肝硬化門靜脈高壓癥46例

62、Keywords Bie Jia Jian;Cirrhotic;Liver fibrosis;Bilirubin;Hemoglutination function; ─── 加減鱉甲煎;肝硬化;肝纖四項;膽紅素;凝血功能;

63、Materials and Methods: Ten cirrhotic patients (group A) underwent minor liver resections due to hepatocellular carcinoma (HCC). ─── 方法和材料：10個肝硬化患者（A組）因為肝細胞癌行肝次全切。

64、Effect of helicobacter pylori infection on hyperdynamic circulatory state and portal hypertensive gastrropathy in liver cirrhotic patients ─── 幽門螺桿菌感染在肝硬化、肝癌高動力循環(huán)及胃黏膜病變中的作用

65、It is also arising in a cirrhotic (nodular) liver. ─── 此病變也可由肝硬化發(fā)展而來。

66、3 Terg R, Berreta J, Abecasis R, et al. Dextran administration avoids hemodynamie changes following paracentesis in cirrhotic patients. ─── 2貢齊鐵，姚希賢，姜慧卿.排放腹水、靜脈輸注白蛋白對肝硬變患者有效血容量、電解質(zhì)和腎功能的影響.中華消化雜志，1995；15(3)：186

67、Many of the known risk factors for postmenopausal osteoporosis exist in the cirrhotic population, such as excess alcohol intake, steroid use, poor nutrition, and hypogonadism. ─── 尤其那些血色沉著病和膽道疾病患者雖無肝硬化但骨質(zhì)疏松風險可能會更高。

68、Materials and Methods:Cirrhotic patients needed for interventional therapy were assigned into group D (DIPS) and group T (TIPS) randomly. ─── 材料和方法:隨機將需行介入治療的肝硬化門脈高壓患者分入DIPS(D組)及TIPS(T組)。

69、Expression of nitric oxide synthase in human hepatocellular carcinoma and cirrhotic liver tissue and its clinical significance. ─── 一氧化氮合酶在原發(fā)性肝癌及癌旁肝硬化組織中的表達及其意義。

70、cirrhotic kidney ─── [醫(yī)] 硬變腎, 固縮腎, [顆]粒狀腎

71、To Test the value of therapeutic paracentesis, peritoneal lavage and abdominal antibiotic administration in cirrhotic patients with spontaneous bacterial peritonitis(SBP). ─── 為探討腹腔穿刺放液,灌洗及注射抗生素對肝硬化合并自發(fā)性細菌性腹膜炎(SBP)的治療價值。

72、Prof. McCullough: Every cirrhotic patient has a loss in protein even if it is undetectable by standard methods clinically. ─── 每位肝硬化患者都存在蛋白質(zhì)過多的損耗，有時甚至使用標準臨床方法也檢測不出來。

73、Study on Application of TIPSS in the Treatment of Cirrhotic Portal Hypertension ─── TIPSS治療肝硬化門脈高壓的應用研究

74、cirrhotic tuberculosis ─── [醫(yī)] 閉鎖性肺結(jié)核, 非開放性肺結(jié)核

75、Method 90 Cirrhotic patients with HE were randomly divided into two groups. ─── 方法肝硬化合并肝性腦病90例,隨機分成治療組和對照組。

76、The two other patients were cirrhotic, but had no further identifiable risk factors. ─── 其它兩個病人有肝硬化，但并未發(fā)現(xiàn)其他危險因素。

77、Methods: Between 1997 and 2006, we selected 45 cirrhotic patients with hepatocellular carcinoma distributed into two groups according to explant histology: MC and Expanded Milan Criteria (EMC). ─── 方法： 1997年至2006年間，我們選定了45名肝硬化肝癌患者，并根據(jù)外植體組織學將其分成兩組：MC組和擴大米蘭標準（EMC）組。

78、Experimental study of applying recombinant human growth hormone to treat cirrhotic rats with ascites ─── 應用重組人生長激素治療肝硬化腹水大鼠的實驗研究

79、Methods Investigate the relationship of the electrolyte's turbulences and ascites levels and hepatic encephalopathy by statistical analysis of 121 cases of cirrhotic Ascites. ─── 方法本文分析總結(jié)了肝硬化腹水病人121例，通過統(tǒng)計學處理了解電解質(zhì)紊亂與腹水程度、肝性腦病的關系。

80、Portacaval shunts have been performed for recent variceal hemorrhage in cirrhotic patients without the physician suspecting that a hepatoma was responsible for the portal hypertension. ─── 在肝硬化患者的門靜脈與腔靜脈的吻合分流處新近出現(xiàn)的靜脈曲張出血癥狀，醫(yī)師卻沒有懷疑到這是肝細胞瘤引起血壓過度緊張造成的。

81、Methods: A total of 50 cirrhotic patients who underwent both endoscopy and multislice spiral CT within a 4-week interval were prospectively evaluated. ─── 方法：納入肝硬化患者50例，在4周內(nèi)分別行內(nèi)鏡和多層螺旋CT檢查。

82、Prognostic evaluation of non-alcoholic cirrhotic patients by means of MELD score combined with HDL-ch levels ─── MELD評分聯(lián)合血清高密度脂蛋白膽固醇水平預測非酒精性肝硬化預后

83、Methods We used a radioimmunoassy to determine serum leptin concentrations in 43 cirrhotic patients with normal renal function and 30 controls matched for gender, age and body mass index(BMI). ─── 方法選擇腎功能正常的43例肝硬化患者和30例與其在性別、年齡和體重指數(shù)(BMI)相匹配的對照者，應用放免法測定血清瘦素。

84、Materials and Methods: Percutanous splenic artery DSA was performed in 20 patients with cirrhotic portal hypertension befor operation and 2 years after operation repeetively. ─── 材料與方法：對20例患者于術(shù)前、術(shù)后2年分別行脾動脈DSA檢查。

85、As a result, "a patient may be told at one point that he or she has mild disease, only to find out a year later that the liver is cirrhotic," he said. ─── 他用一組硬化患者肝穿的橫斷面樣本幻燈解釋示意。針頭可以穿在一個位置但是錯過旁邊的硬化組織，但是只要將針頭移動幾個毫米就檢查到深度硬化的組織。

86、Methods The esophageal varices of 45 cases with cirrhotic patients were treated by endoscopic sclerotherapy with non-water ethanol totalling 96 times. ─── 方法對我院45例肝硬化并發(fā)食管靜脈曲張的患者,在內(nèi)鏡下用無水酒精行96次靜脈內(nèi)注射。

87、Methods Retrospectively analysis were ultrasound findings in 8 patients of Budd-Chiari syndrome and 30 patients of cirrhotic portal hypertension. ─── 方法 回顧性分析8例布加綜合征和30例門脈性肝硬化患者的超聲影像資料。

88、Effects of erythropoietin or nitric oxide synthesis inhibitor on hyperdynamic circulatory state in cirrhotic rats. ─── 促紅細胞生成素與一氧化氮合酶抑制劑對肝硬化大鼠高動力循環(huán)狀態(tài)的影響。

89、The effects of disconnection and shunt procedure on hepatic hemodynamics and function of active cirrhotic patients with portal hypertension ─── 不同術(shù)式對活動性肝硬化門靜脈高壓癥患者肝臟血流動力學和肝功能的影響